Trajectories of stroke severity and functional outcomes after endovascular treatment in ischemic stroke : A post hoc analysis of a randomized controlled trial
Copyright © 2024 Elsevier B.V. All rights reserved..
BACKGROUND: The trajectory of early neurological changes in patients with acute ischemic stroke has been understudied. This study aimed to investigate the association between longitudinal trajectories of stroke severity and 90-day functional outcomes in patients with acute ischemic stroke receiving endovascular treatment.
METHODS: We enrolled patients from a prospective, multicenter, randomized controlled trial. The stroke severity was assessed with the National Institute of Health Stroke Scale at the pre-procedure, 24 hours, and seven days after the procedure. Group-based trajectory modeling (GBTM) was used to identify trajectories of stroke severity. Multivariable logistic regression was performed to explore the association between stroke severity markers and 90-day functional outcomes.
RESULTS: Of 218 enrolled patients, 127 (58.3%) had poor functional outcomes at 90 days. We identified three trajectories of stroke severity in the GBTM: stable symptom (38.1%), symptom deterioration (17.0%), and symptom improvement (44.9%). In multivariable analyses, trajectories of stroke severity were associated with an increased risk of poor functional outcomes (symptom improvement versus symptom deterioration: odds ratio, 0.007; 95% confidence interval, 0.001-0.040; P <0.001). Reclassification indexes revealed that trajectories of stroke severity would increase the predictive ability for poor functional outcomes at 90 days.
CONCLUSION: After endovascular treatment, patients would follow one of three distinct trajectories of stroke severity. Symptom deterioration trajectory was associated with an increased risk of poor functional outcomes at 90 days.
TRIAL REGISTRATION NUMBER: NCT04973332.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:239 |
|---|---|
| Enthalten in: |
Clinical neurology and neurosurgery - 239(2024) vom: 01. Apr., Seite 108248 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Huo, Shuxian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Ischemic stroke |
|---|
| Anmerkungen: |
Date Completed 02.04.2024 Date Revised 02.04.2024 published: Print-Electronic ClinicalTrials.gov: NCT04973332 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.clineuro.2024.108248 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369975715 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369975715 | ||
| 003 | DE-627 | ||
| 005 | 20240403000547.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clineuro.2024.108248 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1361.xml |
| 035 | |a (DE-627)NLM369975715 | ||
| 035 | |a (NLM)38507987 | ||
| 035 | |a (PII)S0303-8467(24)00135-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Huo, Shuxian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Trajectories of stroke severity and functional outcomes after endovascular treatment in ischemic stroke |b A post hoc analysis of a randomized controlled trial |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.04.2024 | ||
| 500 | |a Date Revised 02.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT04973332 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Elsevier B.V. All rights reserved. | ||
| 520 | |a BACKGROUND: The trajectory of early neurological changes in patients with acute ischemic stroke has been understudied. This study aimed to investigate the association between longitudinal trajectories of stroke severity and 90-day functional outcomes in patients with acute ischemic stroke receiving endovascular treatment | ||
| 520 | |a METHODS: We enrolled patients from a prospective, multicenter, randomized controlled trial. The stroke severity was assessed with the National Institute of Health Stroke Scale at the pre-procedure, 24 hours, and seven days after the procedure. Group-based trajectory modeling (GBTM) was used to identify trajectories of stroke severity. Multivariable logistic regression was performed to explore the association between stroke severity markers and 90-day functional outcomes | ||
| 520 | |a RESULTS: Of 218 enrolled patients, 127 (58.3%) had poor functional outcomes at 90 days. We identified three trajectories of stroke severity in the GBTM: stable symptom (38.1%), symptom deterioration (17.0%), and symptom improvement (44.9%). In multivariable analyses, trajectories of stroke severity were associated with an increased risk of poor functional outcomes (symptom improvement versus symptom deterioration: odds ratio, 0.007; 95% confidence interval, 0.001-0.040; P <0.001). Reclassification indexes revealed that trajectories of stroke severity would increase the predictive ability for poor functional outcomes at 90 days | ||
| 520 | |a CONCLUSION: After endovascular treatment, patients would follow one of three distinct trajectories of stroke severity. Symptom deterioration trajectory was associated with an increased risk of poor functional outcomes at 90 days | ||
| 520 | |a TRIAL REGISTRATION NUMBER: NCT04973332 | ||
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Ischemic stroke | |
| 650 | 4 | |a National Institutes of Health Stroke Scale | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Thrombectomy | |
| 650 | 4 | |a Trajectory | |
| 700 | 1 | |a Gao, Jie |e verfasserin |4 aut | |
| 700 | 1 | |a Lv, Qiushi |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Mengdi |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Huaiming |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Xiaohao |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Min |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Rui |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Xinfeng |e verfasserin |4 aut | |
| 700 | 1 | |a Yuan, Kang |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Ruidong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical neurology and neurosurgery |d 1993 |g 239(2024) vom: 01. Apr., Seite 108248 |w (DE-627)NLM000340820 |x 1872-6968 |7 nnns |
| 773 | 1 | 8 | |g volume:239 |g year:2024 |g day:01 |g month:04 |g pages:108248 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clineuro.2024.108248 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 239 |j 2024 |b 01 |c 04 |h 108248 | ||